BACH1 has recently gained visibility as a potential therapeutic target against a variety of conditions ranging from Parkinson's disease [18], bone destructive diseases [24], non-alcoholic steatohepatitis [30], atherosclerosis [31], insulin resistance [28], coronary artery disease [51] and aging related conditions [25]. The gene discussed is BACH1; the disease is metabolic dysfunction-associated steatohepatitis.